Back |
home / stock / sndx / sndx message board
Subject | By | Source | When |
---|---|---|---|
SNDX, $NKTR ink clinical-trial collaboration for Entinostat + | DewDiligence | investorshub | 05/30/2018 9:04:43 PM |
$SNDX ENCORE-601 update | DewDiligence | investorshub | 05/17/2018 1:24:34 PM |
After failure of two high profile IO combination, | tika1 | investorshub | 05/15/2018 2:17:31 AM |
Transcript of $SNDX 1Q18 CC: | DewDiligence | investorshub | 05/10/2018 3:51:33 PM |
$SNDX new investor slide set: | DewDiligence | investorshub | 05/09/2018 8:24:35 PM |
The 1Q18 10-Q has been filed: | DewDiligence | investorshub | 05/09/2018 8:15:20 PM |
$SNDX 1Q18 resultscash=$113M: | DewDiligence | investorshub | 05/08/2018 9:17:20 PM |
$SNDX ASCO lineup: | DewDiligence | investorshub | 04/25/2018 8:38:21 PM |
Yesplease see my reply in #msg-140012720. | DewDiligence | investorshub | 04/13/2018 1:21:06 PM |
Dew, | tika1 | investorshub | 04/13/2018 1:10:07 PM |
$SNDX presentation lineup at AACR: | DewDiligence | investorshub | 04/13/2018 11:56:00 AM |
The annual-report proxy has been filed: | DewDiligence | investorshub | 04/10/2018 8:13:58 PM |
The 2017 10-K has been filed: | DewDiligence | investorshub | 03/08/2018 11:08:00 PM |
SNDX 4Q17 CC slides: | DewDiligence | investorshub | 03/05/2018 9:56:29 PM |
$SNDX 4Q17 results/2018 news-flow12/31/17 cash=$133.2M: | DewDiligence | investorshub | 03/05/2018 9:16:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Syndax Pharmaceuticals Inc. Company Name:
SNDX Stock Symbol:
NASDAQ Market:
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors PR Newswire WALTHAM, Mass. , May 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of...
2024-05-14 04:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference PR Newswire WALTHAM, Mass. , May 9, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeli...